Phospho-TERF1 (S219) Antibody

What is TERF1 and why is phosphorylation at S219 significant?

Telomeric repeat binding factor 1 (TERF1, also known as TRF1) is a critical component of the shelterin complex that regulates telomere length and protection. TRF1 negatively regulates telomere elongation by binding to the telomeric double-stranded 5'-TTAGGG-3' repeat sequences . The phosphorylation of TRF1 at serine 219 (S219) is particularly significant as it occurs in an ATM-dependent manner in response to ionizing DNA damage . This post-translational modification is part of the cellular response to DNA damage and may influence telomere maintenance mechanisms during cellular stress.

Unlike TRF2 which has a basic N-terminus and primarily functions to protect chromosome ends by inhibiting end-to-end fusions, TRF1 has an acidic N-terminus and serves as a negative regulator of telomere elongation . The phosphorylation status of TRF1 at S219 can therefore serve as an important biomarker for DNA damage response at telomeres.

What applications are Phospho-TERF1 (S219) antibodies typically used for?

Phospho-TERF1 (S219) antibodies are primarily utilized in Western Blot (WB) and ELISA applications . These applications allow researchers to:

• Detect endogenous levels of TRF1 specifically when phosphorylated at Ser219

• Monitor DNA damage responses affecting telomeric proteins

• Study ATM-dependent phosphorylation pathways

• Investigate telomere maintenance mechanisms during cellular stress

The antibodies are particularly valuable for studying how various treatments, such as UV radiation or other DNA-damaging agents, affect the phosphorylation status of TRF1 at this specific residue. For example, Western blot analysis has been performed on various cell lysates treated with UV radiation for 4 hours, demonstrating increased phosphorylation of TRF1 at S219 .

What is the molecular specificity of commercially available Phospho-TERF1 (S219) antibodies?

Commercially available Phospho-TERF1 (S219) antibodies demonstrate high specificity for the phosphorylated form of TRF1. These antibodies:

• Detect endogenous levels of TRF1 only when phosphorylated at Ser219

• Are typically raised against synthetic phosphopeptides derived from human TRF1 around the phosphorylation site of Serine 219

• Recognize a protein of approximately 55 kDa molecular weight

• Show cross-reactivity with human and mouse samples, with some antibodies also reacting with rat samples

• Are affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogen, resulting in >95% purity (by SDS-PAGE)

The immunogen used for antibody production generally corresponds to the amino acid region 185-234 of human TERF1, which contains the S219 phosphorylation site .

What are the optimal conditions for Western blot detection of phosphorylated TERF1?

For optimal Western blot detection of phosphorylated TERF1 at S219, the following protocol parameters are recommended:

Sample Preparation:

• Include phosphatase inhibitors in lysis buffers to preserve phosphorylation status

• Use cells treated with DNA-damaging agents like UV radiation as positive controls

Antibody Dilution:

• Typical working dilutions range from 1:500 to 1:2000 for Western blot applications

• Optimize antibody concentration based on signal-to-noise ratio in preliminary experiments

Blocking and Washing:

• Use 5% BSA in TBST for blocking rather than milk, as milk contains phosphatases that may reduce signal

• Perform stringent washing steps to minimize background

Detection System:

• Secondary antibodies conjugated to HRP are commonly used

• Compatible secondary antibodies include Goat Anti-Rabbit IgG H&L Antibody (HRP)

Controls:

• Include both phosphorylated (e.g., UV-treated cells) and non-phosphorylated samples

• Consider using lambda phosphatase-treated samples as negative controls

Validation data from antibody manufacturers shows successful detection in various cell lines including DLD, Raw264.7, and PC12 cells treated with UV radiation for 4 hours , and in 293 cells .

How should researchers prepare samples to maximize detection of phosphorylated TERF1?

Proper sample preparation is crucial for reliable detection of phosphorylated TERF1:

• Cellular Stress Induction:

  • Use DNA damaging agents such as UV radiation (commonly applied for 4 hours)

  • Ionizing radiation can also be used to activate ATM-dependent phosphorylation

• Cell Lysis Protocol:

  • Lyse cells in ice-cold buffer containing:

    • 50 mM Tris-HCl (pH 7.5)

    • 150 mM NaCl

    • 1% NP-40 or Triton X-100

    • 0.5% sodium deoxycholate

    • Protease inhibitor cocktail

    • Critical: Phosphatase inhibitor cocktail (e.g., sodium fluoride, sodium orthovanadate, β-glycerophosphate)

• Sample Handling:

  • Keep samples on ice throughout processing

  • Avoid repeated freeze-thaw cycles of lysates

  • Process samples quickly to prevent phosphatase activity

• Protein Denaturation:

  • Add SDS sample buffer and heat at 95°C for 5 minutes

  • For phospho-proteins, avoid excessive heating which may cause dephosphorylation

• Loading Controls:

  • Include total TRF1 antibody on separate blots or after stripping

  • Use housekeeping proteins such as β-actin as loading controls

These preparation steps maximize the likelihood of detecting the phosphorylated form of TERF1 while minimizing dephosphorylation during sample handling.

What are appropriate positive and negative controls for Phospho-TERF1 (S219) antibody experiments?

Establishing proper controls is essential for interpreting results with Phospho-TERF1 (S219) antibodies:

Positive Controls:

• Cell lysates from UV-treated cells (4 hour treatment is commonly used)

• Cell lines known to exhibit DNA damage responses, such as DLD, Raw264.7, PC12, or 293 cells

• Cells treated with ATM activators or DNA damaging agents

Negative Controls:

• Untreated cell lysates

• Lambda phosphatase-treated samples to remove phosphorylation

• siRNA or CRISPR knockout of TERF1 to confirm antibody specificity

• Cells treated with ATM inhibitors before DNA damage induction

• Competing peptide blocking experiments using the immunizing phosphopeptide

Additional Control Strategies:

• Dual detection with total TRF1 antibody to normalize phospho-signal

• Inclusion of multiple cell types to demonstrate conservation of phosphorylation patterns

• Time-course experiments to show temporal changes in phosphorylation status

Implementing these controls helps verify antibody specificity and ensures accurate interpretation of experimental results.

How does ATM-dependent phosphorylation of TERF1 at S219 affect telomere maintenance?

ATM-dependent phosphorylation of TERF1 at S219 represents a critical regulatory mechanism in telomere maintenance:

TERF1 is preferentially phosphorylated on Ser-219 in an ATM-dependent manner in response to ionizing DNA damage . This phosphorylation event is part of the DNA damage response (DDR) network that protects genomic integrity at telomeres. The functional consequences include:

• Altered Binding Properties: Phosphorylation may modify TERF1's affinity for telomeric DNA, potentially allowing access to DNA repair machinery

• Integration with Other Post-translational Modifications: Phosphorylation works in concert with other modifications. For instance, ADP-ribosylation by TNKS1 or TNKS2 diminishes TERF1's ability to bind to telomeric DNA

• Protein Stability Regulation: Phosphorylation may influence subsequent ubiquitination events. TERF1 can be ubiquitinated by RLIM/RNF12 or by a SCF (SKP1-CUL1-F-box protein) ubiquitin-protein ligase complex, leading to its degradation by the proteasome

• Cell Cycle Coordination: The phosphorylation status may vary throughout the cell cycle, coordinating telomere maintenance with DNA replication

• Shelterin Complex Dynamics: As a component of the shelterin complex, phosphorylated TERF1 may influence interactions with other shelterin proteins (TRF2, POT1, TIN2, TPP1, and RAP1)

Understanding these mechanisms provides insight into how cells maintain telomere integrity in response to genotoxic stress, with implications for cancer research and aging studies.

What technical challenges exist in distinguishing between phosphorylated and non-phosphorylated forms of TERF1?

Researchers face several technical challenges when attempting to differentiate between phosphorylated and non-phosphorylated forms of TERF1:

Antibody Specificity Issues:

• Cross-reactivity with other phosphorylated proteins sharing similar epitopes

• Potential non-specific binding to non-phosphorylated TERF1

• Variable affinity for differentially phosphorylated forms (TERF1 has multiple phosphorylation sites)

Sample Preparation Limitations:

• Rapid dephosphorylation during sample processing due to endogenous phosphatases

• Phosphorylation status can change during cell lysis and protein extraction

• Challenges in extracting nuclear proteins while maintaining phosphorylation state

Detection Sensitivity:

• Low abundance of phosphorylated form relative to total TERF1 pool

• Signal-to-noise ratio challenges in Western blot applications

• Need for enrichment strategies for low-abundance phosphoproteins

Resolution Considerations:

• Minor shift in molecular weight between phosphorylated and non-phosphorylated forms

• Requirement for high-resolution gel systems (e.g., Phos-tag™ SDS-PAGE)

• Potential masking of phosphorylation by other post-translational modifications

Quantification Difficulties:

• Establishing reliable normalization methods between phospho-TERF1 and total TERF1

• Accounting for background signal in densitometry analyses

• Variations in antibody affinities between phospho-specific and total protein antibodies

Addressing these challenges requires careful experimental design, appropriate controls, and often the use of complementary techniques such as mass spectrometry to validate Western blot findings.

How can Phospho-TERF1 (S219) antibody be used to investigate DNA damage responses?

Phospho-TERF1 (S219) antibody serves as a valuable tool for investigating DNA damage responses, particularly those affecting telomere biology:

Experimental Approaches:

• Treatment Response Studies:

  • Monitor phosphorylation kinetics after exposure to:

    • UV radiation (commonly used at 4-hour exposure)

    • Ionizing radiation

    • Chemotherapeutic agents

    • Oxidative stress inducers

• Cell Type Comparative Analysis:

  • Compare phosphorylation patterns across:

    • Cancer vs. normal cells

    • Senescent vs. proliferating cells

    • Cells with varying telomere lengths

    • Multiple cell lines (e.g., DLD, Raw264.7, PC12, 293)

• Pathway Inhibition Studies:

  • Pretreat cells with inhibitors of:

    • ATM kinase (direct regulator of S219 phosphorylation)

    • Upstream DNA damage sensors

    • Checkpoint kinases

• Colocalization Analysis:

  • Combine with immunofluorescence to assess:

    • Colocalization with γ-H2AX foci (DNA damage marker)

    • Association with other shelterin complex components

    • Nuclear vs. cytoplasmic distribution

• Correlation with Telomere Dysfunction:

  • Link phosphorylation status to:

    • Telomere length measurements

    • Telomere fragility assays

    • Chromosome end-to-end fusion events

    • Alternative lengthening of telomeres (ALT) activity

By applying these strategies, researchers can gain insights into how TERF1 phosphorylation contributes to telomere protection mechanisms during genotoxic stress and identify potential targets for intervention in diseases characterized by telomere dysfunction.

How should researchers troubleshoot weak or absent signals with Phospho-TERF1 (S219) antibody?

When encountering weak or absent signals when using Phospho-TERF1 (S219) antibody, consider the following systematic troubleshooting approach:

Sample Preparation Issues:

• Verify inclusion of phosphatase inhibitors in lysis buffer

• Ensure sample was properly treated to induce phosphorylation (e.g., UV treatment for 4 hours)

• Check protein concentration and increase loading amount if necessary

• Avoid excessive sample heating which may cause dephosphorylation

Antibody-Related Factors:

• Adjust antibody dilution (try concentrations between 1:500-1:2000)

• Verify antibody storage conditions (should be at -20°C or -80°C, avoid repeated freeze-thaw)

• Check antibody expiration date

• Consider using a fresh aliquot of antibody

Detection System Optimization:

• Increase exposure time during imaging

• Use enhanced chemiluminescence (ECL) substrate with higher sensitivity

• Ensure secondary antibody is compatible with primary antibody host species (rabbit)

• Verify secondary antibody dilution and activity

Protocol Modifications:

• Extend primary antibody incubation time (overnight at 4°C)

• Optimize blocking conditions (5% BSA instead of milk)

• Increase membrane washing stringency to reduce background

• Consider signal amplification methods

Positive Control Verification:

• Run a known positive control sample (UV-treated cells)

• Confirm total TRF1 detection on a parallel blot to verify protein presence

Creating a systematic troubleshooting log helps track modifications and their effects on signal intensity. If problems persist, consider testing an alternative phospho-TERF1 (S219) antibody from a different manufacturer.

How can phosphatase inhibitors improve detection of Phospho-TERF1 (S219)?

Phosphatase inhibitors play a crucial role in preserving the phosphorylation status of TERF1 during sample preparation:

Mechanism of Action:
Phosphatases rapidly dephosphorylate proteins during cell lysis and sample processing. Phosphatase inhibitors prevent this activity, maintaining the native phosphorylation state of proteins like TERF1 at S219.

Recommended Inhibitor Cocktail Components:

• Serine/Threonine Phosphatase Inhibitors:

  • Sodium fluoride (NaF): 10-50 mM

  • β-Glycerophosphate: 10-50 mM

  • Sodium pyrophosphate: 2-5 mM

• Tyrosine Phosphatase Inhibitors:

  • Sodium orthovanadate (Na₃VO₄): 1-2 mM (must be activated by boiling)

  • Sodium pervanadate: 0.1-1 mM (freshly prepared)

• Broad-spectrum Inhibitors:

  • Okadaic acid: 1 μM (PP1 and PP2A inhibitor)

  • Calyculin A: 100 nM (PP1 and PP2A inhibitor)

Implementation Strategy:

• Add inhibitors to all buffers used during sample preparation

• Prepare fresh inhibitor cocktails before each experiment

• Keep samples cold (on ice) throughout processing

• Process samples quickly to minimize dephosphorylation time

• Consider using commercially available phosphatase inhibitor cocktails for consistency

Experimental Validation:
Process identical samples with and without phosphatase inhibitors to demonstrate their impact on phospho-TERF1 (S219) detection. This side-by-side comparison can serve as an educational control for training purposes and method optimization.

Proper implementation of phosphatase inhibitors can significantly improve the sensitivity and reproducibility of phospho-TERF1 (S219) detection in Western blot and ELISA applications.

What statistical approaches are appropriate for analyzing changes in TERF1 phosphorylation?

Quantification Methods:

• Densitometry Analysis:

  • Normalize phospho-TERF1 (S219) band intensity to:

    • Total TERF1 from parallel blots

    • Loading controls (β-actin, GAPDH)

  • Use digital imaging software with linear dynamic range

  • Avoid saturated signals that prevent accurate quantification

• Relative Quantification:

  • Express data as fold-change relative to control condition

  • Calculate phospho-TERF1/total TERF1 ratio for each sample

Statistical Tests for Group Comparisons:

• For Two Groups:

  • Student's t-test (parametric) if data are normally distributed

  • Mann-Whitney U test (non-parametric) if normality cannot be assumed

• For Multiple Groups:

  • One-way ANOVA with appropriate post-hoc tests (Tukey, Bonferroni) for parametric data

  • Kruskal-Wallis with Dunn's post-hoc test for non-parametric data

• For Time-course Experiments:

  • Repeated measures ANOVA

  • Mixed-effects models for handling missing data points

Technical Considerations:

• Perform at least three biological replicates

• Consider technical replicates within each biological replicate

• Test for normality using Shapiro-Wilk or D'Agostino-Pearson test

• Transform data (log, square root) if needed to achieve normality

• Use Levene's test to verify homogeneity of variance

Advanced Analytical Approaches:

• Correlation analysis between phosphorylation level and functional outcomes

• Multiple regression to assess contributions of various factors

• Principal component analysis for complex experimental designs with multiple variables

How does TERF1 phosphorylation interact with other post-translational modifications?

TERF1 undergoes multiple post-translational modifications that interact in complex ways to regulate its function:

Interaction Network of Post-translational Modifications:

• Phosphorylation and ADP-ribosylation:

  • ADP-ribosylation by TNKS1 or TNKS2 diminishes TERF1's ability to bind to telomeric DNA

  • Phosphorylation at S219 may influence susceptibility to ADP-ribosylation

  • Both modifications may work in concert to regulate TERF1 release from telomeres during DNA damage response

• Phosphorylation and Ubiquitination:

  • TERF1 can be ubiquitinated by RLIM/RNF12 or by a SCF (SKP1-CUL1-F-box protein) ubiquitin-protein ligase complex

  • Phosphorylation often serves as a priming event for ubiquitination

  • The interplay may control protein stability and half-life during cellular stress

• Multiple Phosphorylation Sites:

  • Besides S219, TERF1 contains other phosphorylation sites

  • Hierarchical phosphorylation may occur, where modification at one site influences others

  • Different kinases (beyond ATM) may target TERF1 in response to various cellular signals

Research Methods for Studying Modification Crosstalk:

• Mass spectrometry to identify co-occurring modifications

• Site-directed mutagenesis to create phospho-mimetic or phospho-deficient mutants

• Temporal analysis of modification sequences during DNA damage response

• Inhibitor studies targeting specific enzymes in modification pathways

Understanding this complex interplay provides insight into how cells fine-tune telomere maintenance through multilayered regulation of TERF1 activity.

What role does TERF1 phosphorylation play in cancer and aging research?

The phosphorylation of TERF1 at S219 has significant implications for both cancer and aging research:

Cancer Research Applications:

• Telomere dysfunction is a hallmark of cancer

• Down-regulation of TRF expression in tumor cells may contribute to cell immortalization and malignant progression

• TERF1 phosphorylation status could serve as:

  • A biomarker for DNA damage response activation in tumors

  • An indicator of telomere maintenance mechanism activity

  • A potential therapeutic target for cancer treatment

Aging Research Implications:

• Telomere shortening correlates with cellular aging and senescence

• TERF1 regulation influences telomere length maintenance

• Phosphorylation of TERF1 may affect:

  • Senescence induction after DNA damage

  • Age-related telomere dysfunction

  • Response to genotoxic stress in aged cells

Research Directions:

• Clinical Correlations:

  • Analyzing phospho-TERF1 (S219) levels in:

    • Tumor vs. normal tissue samples

    • Young vs. aged tissue samples

    • Patients with telomere-related disorders

• Therapeutic Targeting:

  • Developing small molecule modulators of TERF1 phosphorylation

  • Exploring kinase inhibitors that affect ATM-dependent phosphorylation

  • Investigating combination approaches with DNA damaging agents

• Biomarker Development:

  • Validating phospho-TERF1 (S219) as a prognostic or predictive biomarker

  • Correlating phosphorylation status with treatment response or disease progression

  • Developing high-throughput detection methods for clinical applications

By exploring these research avenues, scientists can gain deeper insights into how TERF1 phosphorylation contributes to disease processes and potentially identify novel therapeutic strategies.

How can researchers optimize immunofluorescence protocols for Phospho-TERF1 (S219) detection?

While the provided search results focus primarily on Western blot and ELISA applications, researchers may also wish to detect phosphorylated TERF1 by immunofluorescence. Here is a specialized protocol optimization guide:

Fixation and Permeabilization:

• Use 4% paraformaldehyde (10-15 minutes at room temperature) to preserve phospho-epitopes

• Avoid methanol fixation which can cause epitope masking

• Permeabilize with 0.1-0.2% Triton X-100 (5-10 minutes)

• Consider additional permeabilization with 0.5% saponin for better nuclear access

Antigen Retrieval Options:

• Citrate buffer (pH 6.0) heating (95°C for 10-15 minutes)

• EDTA buffer (pH 8.0) for alternative epitope unmasking

• Test multiple retrieval methods to determine optimal conditions

Blocking and Antibody Incubation:

• Block with 5% BSA (not milk) to avoid phosphatase activity

• Include phosphatase inhibitors in blocking and antibody dilution buffers

• Use overnight primary antibody incubation at 4°C

• Test dilutions between 1:100-1:500 for immunofluorescence applications

Signal Amplification Strategies:

• Consider tyramide signal amplification (TSA) for weak signals

• Use high-sensitivity fluorophore-conjugated secondary antibodies

• Evaluate quantum dot-conjugated secondaries for photostable signal

Co-localization Studies:

• Combine with γ-H2AX antibodies to correlate with DNA damage sites

• Co-stain with other shelterin components (TRF2, POT1)

• Use telomere FISH probes to confirm telomeric localization

Controls:

• Include UV-treated cells as positive controls

• Use lambda phosphatase-treated samples as negative controls

• Perform peptide competition assays with immunizing phosphopeptide

Imaging Considerations:

• Use confocal microscopy for better resolution of nuclear foci

• Perform z-stack imaging to capture the full nuclear volume

• Consider super-resolution techniques for detailed co-localization studies

Optimization of these parameters will enable detection of phosphorylated TERF1 in situ, providing spatial information about its distribution and co-localization with other proteins during the DNA damage response.

What emerging technologies might enhance future studies of TERF1 phosphorylation?

Several cutting-edge technologies show promise for advancing our understanding of TERF1 phosphorylation beyond current methodologies:

• Proximity Ligation Assays (PLA):

  • Allows visualization of protein interactions and modifications in situ

  • Could detect phosphorylated TERF1 with single-molecule sensitivity

  • Enables co-localization studies with other shelterin components

• CRISPR/Cas9 Genome Editing:

  • Generation of TERF1 phospho-mimetic (S219D/E) or phospho-deficient (S219A) mutants

  • Knock-in of tagged TERF1 variants for live-cell imaging

  • Creation of cell lines with modified ATM-dependent phosphorylation sites

• Live-Cell Imaging of Phosphorylation:

  • Phosphorylation-specific fluorescent biosensors

  • FRET-based reporters of TERF1 conformational changes upon phosphorylation

  • Real-time visualization of kinase activity at telomeres

• Mass Spectrometry Advancements:

  • Targeted proteomics approaches for quantitative analysis of TERF1 phosphorylation

  • Sequential window acquisition of all theoretical mass spectra (SWATH-MS)

  • Phosphoproteomics to identify novel phosphorylation sites

• Single-Cell Technologies:

  • Single-cell phosphoproteomics to assess cell-to-cell variability

  • Spatial proteomics to map phosphorylated TERF1 localization

  • Single-cell Western blotting for heterogeneity analysis

• Computational and AI Approaches:

  • Machine learning algorithms to predict phosphorylation effects on protein function

  • Molecular dynamics simulations of phosphorylated vs. non-phosphorylated TERF1

  • Network analysis of phosphorylation-dependent protein interactions

These emerging technologies will enable more sensitive, specific, and comprehensive analysis of TERF1 phosphorylation dynamics in diverse biological contexts, potentially revealing new regulatory mechanisms and therapeutic targets.

What are the most promising future research directions involving Phospho-TERF1 (S219)?

Based on current knowledge and technological capabilities, several research directions show particular promise:

• Therapeutic Targeting:

  • Development of small molecules that modulate TERF1 phosphorylation

  • Exploration of synthetic lethality approaches in cancer cells with telomere dysfunction

  • Creation of phosphorylation-dependent degraders (PROTACs) targeting TERF1

• Structural Biology:

  • Determination of crystal structures of phosphorylated vs. non-phosphorylated TERF1

  • Analysis of how phosphorylation affects TERF1 binding to telomeric DNA

  • Structural studies of phospho-TERF1 interactions with other shelterin components

• Systems Biology Approaches:

  • Comprehensive mapping of the TERF1 phosphorylation-dependent interactome

  • Integration of phosphoproteomics with transcriptomics and metabolomics data

  • Modeling of dynamic phosphorylation changes during DNA damage response

• Translational Research:

  • Development of phospho-TERF1 (S219) as a biomarker in cancer diagnostics

  • Correlation of phosphorylation status with treatment response in clinical samples

  • Investigation of TERF1 phosphorylation in age-related diseases and telomeropathies

• Evolutionary and Comparative Studies:

  • Analysis of TERF1 phosphorylation sites across species

  • Investigation of telomere regulation in organisms with different telomere maintenance strategies

  • Examination of TERF1 phosphorylation in species with exceptional longevity or cancer resistance